Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 32.4 USD -7.32% Market Closed
Market Cap: $945.8m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 45.75 USD with a low forecast of 38.38 USD and a high forecast of 54.6 USD.

CSTL Lowest Forecast
Wall Street Target
38.38 USD
18% Upside
CSTL Average Forecast
Wall Street Target
45.75 USD
41% Upside
CSTL Highest Forecast
Wall Street Target
54.6 USD
69% Upside
Lowest
Price Target
38.38 USD
18% Upside
Average
Price Target
45.75 USD
41% Upside
Highest
Price Target
54.6 USD
69% Upside
Castle Biosciences Inc Competitors:
Price Targets
YUMC
Yum China Holdings Inc
2% Upside
S
SRFM
Surf Air Mobility Inc
273% Upside
YUMC
Yum China Holdings Inc
2% Upside
S
SRFM
Surf Air Mobility Inc
273% Upside

Revenue
Forecast

56% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
56% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 4 years is 7%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

What are analyst estimates?

See Also

Summary
CSTL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSTL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSTL stock valuation using valuation multiples.
Wall Street Estimates
CSTL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSTL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSTL's stock price target?
Price Target
45.75 USD

According to Wall Street analysts, the average 1-year price target for CSTL is 45.75 USD with a low forecast of 38.38 USD and a high forecast of 54.6 USD.

What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
7%

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 4 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.